NCT06552910 Analyzing Anesthetic Techniques in Diabetic Foot Amputation
| NCT ID | NCT06552910 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara City Hospital Bilkent |
| Condition | Diabetic Foot |
| Study Type | OBSERVATIONAL |
| Enrollment | 450 participants |
| Start Date | 2024-07-01 |
| Primary Completion | 2024-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 450 participants in total. It began in 2024-07-01 with a primary completion date of 2024-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Diabetic Foot Amputations: A Comprehensive Review of Anesthetic Procedures and Outcomes Introduction: Diabetic foot is a severe complication of diabetes, often resulting in ulceration, osteomyelitis, and gangrene. Amputation or surgical debridement is the standard treatment for advanced cases. The study aims to evaluate the outcomes of different anesthetic techniques in diabetic foot amputation, specifically comparing peripheral nerve block (PNB) and general anesthesia. Objective: To assess the impact of anesthetic procedures on outcomes in diabetic foot amputation cases using inpatient data. The hypothesis is that PNB will result in fewer postoperative complications than general anesthesia-primary outcome: 30-day mortality; secondary outcomes: composite morbidity and hospital discharge duration. Materials and Methods: This retrospective chart review will analyze medical records of patients with diabetic foot at Ankara Bilkent City Hospital from 2021 to 2023. Inclusion criteria: patients who underwent toe, ankle, or foot amputations. Exclusion criteria: patients under 18, amputations for non-diabetic reasons, and insufficient medical data. Data will include patient demographics, preoperative medications, comorbidities, and surgical details. Major complications, secondary outcomes, and mortality will be primary measures. Statistical Analysis: Descriptive statistics will summarize patient characteristics. Chi-square and Student t-tests will analyze associations between anesthesia type and postoperative outcomes. Kaplan-Meier survival analysis will compare hospital stay durations. Logistic regression will adjust for confounders and assess the impact of anesthetics on complications. Results will be significant at p \< 0.05.
Eligibility Criteria
Inclusion Criteria: Patients diagnosed with diabetic foot requiring amputation. Patients who underwent toe, ankle, or foot amputation. Patients aged 18 years or older. Exclusion Criteria: Patients under the age of 18. Amputations performed for reasons other than diabetic foot. Patients with incomplete or insufficient medical records.
Contact & Investigator
Semih Başkan
STUDY DIRECTOR
Ankara City Hospital Bilkent
Frequently Asked Questions
Who can join the NCT06552910 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Diabetic Foot. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06552910 currently recruiting?
Yes, NCT06552910 is actively recruiting participants. Contact the research team at drsemkan@gmail.com for enrollment information.
Where is the NCT06552910 trial being conducted?
This trial is being conducted at Etimesgut, Turkey (Türkiye).
Who is sponsoring the NCT06552910 clinical trial?
NCT06552910 is sponsored by Ankara City Hospital Bilkent. The principal investigator is Semih Başkan at Ankara City Hospital Bilkent. The trial plans to enroll 450 participants.